Fischer Medical Ventures Limited (NSE:FISCHER)
India · Delayed Price · Currency is INR 36.49
+1.73 (4.98%)
May 22, 2026, 3:29 PM IST
Fischer Medical Ventures Market Cap
Fischer Medical Ventures has a market cap or net worth of 23.75 billion as of May 22, 2026. Its market cap has decreased by -53.96% in one year.
Market Cap
23.75B
Enterprise Value
23.70B
Revenue
2.60B
Ranking
n/a
PE Ratio
60.20
Stock Price
36.49
Market Cap Chart
Since June 8, 2005, Fischer Medical Ventures's market cap has increased from 49.88M to 23.75B, an increase of 47,511.54%. That is a compound annual growth rate of 34.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 23.75B | -12.60% |
| Dec 31, 2025 | 27.17B | -27.86% |
| Dec 31, 2024 | 37.67B | 6,473.59% |
| Dec 29, 2023 | 573.00M | 3,239.74% |
| Dec 30, 2022 | 17.16M | 6.06% |
| Dec 31, 2021 | 16.18M | 167.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.43T |
| Divi's Laboratories | 1.83T |
| Apollo Hospitals Enterprise | 1.20T |
| Cipla | 1.13T |
| Dishman Carbogen Amcis | 30.63B |
| Medi Assist Healthcare Services | 27.78B |
| Solara Active Pharma Sciences | 26.40B |
| Panacea Biotec | 25.64B |